Source:http://linkedlifedata.com/resource/pubmed/id/20177585
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
2010-2-23
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:status |
PubMed-not-MEDLINE
|
| pubmed:month |
Feb
|
| pubmed:issn |
1998-3751
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
41
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
54
|
| pubmed:year |
2009
|
| pubmed:articleTitle |
Surrogate end points and their role in clinical trial.
|
| pubmed:affiliation |
Department of Pharmacology, Government Medical College, Majura Gate, Surat-395 001, India. Email: drjaykaran@yahoo.co.in.
|
| pubmed:publicationType |
Journal Article
|